Furthermore, as the tumor vasculature is typically comprised of highly proliferative ECs whereas the normal vasculature is quiescent, likely due to the difference in the growth factor levels in their respective environment, we used the model to generate predictions of effective strategies that selectively target only the ECs experiencing high VEGF levels observed in the tumor microenvironment. This evidence concerns the gene VEGFA and neoplasm.